Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-24 @ 10:17 PM
NCT ID:
NCT06255535
Eligibility Criteria:
Inclusion Criteria:
* 6-30 years old
* Have the diagnosis of autism spectrum disorder
* ADOS-2 score is higher than the ASD cut-offs
* Comorbid with intelligent disorder, IQ/DQ \< 70
* Primary environmental language is Chinese
* Participant's parents or other legal guardians give informed consent
Exclusion Criteria:
* Genetic Disorders, such as (e.g., Down syndrome, Fragile X syndrome, Rett syndorme), Current or history of severe ADHD, tourette syndrome, psychotic disorders (e.g., schizophrenia, schizoaffective disorder, bipolar disorder)
* Severe self-injury or suicidal behavior exhibited within the past year
* Significant visual, auditory, deafness or motor disability that prevent them from following study procedures
* Current or history diagnosis of epilepsy
* Known severe physical diseases, particularly those affecting the brain
* Metal implantation contradicted by MRI or TMS, such as artificial cardiac pacemakers, stents, cochlear implants
* Respiratory or circulatory conditions increasing sedation risk, such as Apnea syndrome, severe snoring, or other relevant diseases
* All legal guardians are illiterate, unable to read informed documents or complete questionnaires independently
* Received transcranial magnetic stimulation (TMS), transcranial current stimulation (tCS), focused ultrasound (FUS), or other neuromodulation treatment in the last 3 months
* Current participation in other clinical trials
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
30 Years
Study:
NCT06255535
Study Brief:
Protocol Section:
NCT06255535